Neuroscience & Neurodegenerative Disease Biospecimens

Accelerate your research into Alzheimer’s disease, Parkinson’s disease and other neurological disorders with premium-quality samples and rich clinical annotation

Request a Quote

Catalog Every specimen product by condition, including pre-order and custom collections. In Stock Lot-level inventory ready to ship in 2–3 business days, with clinical data on every sample.

All filters

Condition

Condition

Condition

Start typing to see matching condition.

Sample Type

Sample Type

Sample Type
Sample Attributes

Sample Attributes

Format
Volume / Size
Donor Demographics

Donor Demographics

Gender
Age Range
Race / Ethnicity

Start typing to see matching race / ethnicity.

Country of Collection
Medical History

Medical History

Medications

Start typing to see matching medications.

Comorbidities

Start typing to see matching comorbidities.

Allergy List

Start typing to see matching allergy list.

Lab Results, HLA, & Testing

Lab Results, HLA, & Testing

HLA Typing
HLA-A
HLA-B
HLA-C
HLA-DRB1
HLA-DRB4
HLA-DQA1
HLA-DQB1
HLA-DPA1
HLA-DPB1
ABO Type
Rh Type
CMV Status
HIV/HBV/HCV Tested
Syphilis Tested
Flow Data

Flow Data

Has Flow Data
Viable CD45+ (% of singlets)
CD3+ T cells (% of viable CD45+)
CD4+CD8− (% of viable CD45+)
CD4−CD8+ (% of viable CD45+)
CD3−CD16/56+ NK (% of viable CD45+)
CD19+ B cells (% of viable CD45+)
CD14+ monocytes (% of viable CD45+)
Lifestyle

Lifestyle

Tobacco Use
Alcohol Use
Recreational Drug Use
Caffeine Use
Find by ID

Find by ID

Lot #

Start typing to see matching lot #.

Patient ID

Start typing to see matching patient id.

551 lots match
551 lots available
Specimen IDSample TypeBag SizeCells / VolumePrimary DiseaseDiagnosisAllergiesAllergy ListHas Food AllergiesBMICMV StatusHIV/HBV/HCV TestedSyphilis TestedHas Infectious DiseaseInfectious DiseaseTobacco UseYears of SmokingPacks per DayAlcohol UseRecreational Drug UseCaffeine UseABO TypeRh TypeViable CD45+ (% of singlets)CD3+ T cells (% of viable CD45+)CD4+CD8− (% of viable CD45+)CD4−CD8+ (% of viable CD45+)CD3−CD16/56+ NK (% of viable CD45+)CD19+ B cells (% of viable CD45+)CD14+ monocytes (% of viable CD45+)Sample StatusAvailability
Multiple Sclerosis PBMC 72917 121301 Male 46-60 Caucasian Cryopreserved 1 mL 77 50M Ocrevus 600mg - infusion twice a year Aricept 10mg QD Baclofen 30mg BID Trospium chloride 20mg BID Cymbalta 60mg QD Multiple Sclerosis United States 2026 A*03:01:01:01/A*68:01:02:02 — — — — — — — — 184828; 184829; 184830; 184831; 184832; 184833; 184834; 184835; 184836; 184837; 184838; 184839; 184840; 184841; 184842; 184843; 184844; 184845; 184846; 184847; 184848; 184849; 184890; 184891; 184892; 184893; 184894; 184895; 184896; 184897; 184898; 184899; 184900; 184901; 184902; 184903; 184904; 184905; 184906; 184850; 184851; 184852; 184853; 184854; 184855; 184856; 184857; 184858; 184859; 184860; 184861; 184862; 184863; 184864; 184865; 184866; 184867; 184868; 184869; 184870; 184871; 184872; 184873; 184874; 184875; 184878; 184879; 184880; 184881; 184882; 184883; 184884; 184885; 184886; 184887; 184888; 184889PBMC50M cellsMultiple SclerosisMultiple SclerosisNoMRI contrast48.81ReactiveYesNoNoNoYesNONoARH+StoredIn Stock
$1,109
Multiple Sclerosis PBMC 76047 131643 Female 46-60 Caucasian Cryopreserved 1 mL 10 10M copaxone 30mg injection QD Gabapentin 600mg BID Linzess QD Minocycline QD Prozac Lithium SPRAVATO Multiple Sclerosis United States 2026 — — — — — — — — — 203541; 203540; 203539; 203538; 203537; 203536; 203535; 203534; 203531; 203530PBMC10M cellsMultiple SclerosisMultiple SclerosisYesBactrim24.27Non ReactiveYesNoNoUsed to SmokeNoYESYesStoredIn Stock
$530
Multiple Sclerosis PBMC 76047 131643 Female 46-60 Caucasian Cryopreserved 1 mL 79 50M copaxone 30mg injection QD Gabapentin 600mg BID Linzess QD Minocycline QD Prozac Lithium SPRAVATO Multiple Sclerosis United States 2026 — — — — — — — — — 203483; 203482; 203481; 203480; 203479; 203478; 203477; 203476; 203475; 203474; 203529; 203528; 203527; 203526; 203525; 203524; 203523; 203522; 203521; 203520; 203519; 203518; 203517; 203516; 203515; 203514; 203513; 203512; 203511; 203510; 203509; 203508; 203507; 203506; 203505; 203504; 203503; 203502; 203501; 203500; 203499; 203498; 203497; 203496; 203495; 203494; 203493; 203492; 203491; 203490; 203489; 203488; 203487; 203486; 203485; 203484; 203473; 203472; 203471; 203470; 203469; 203468; 203467; 203466; 203465; 203464; 203463; 203456; 203455; 203454; 203453; 203452; 203451; 203462; 203461; 203460; 203459; 203458; 203457PBMC50M cellsMultiple SclerosisMultiple SclerosisYesBactrim24.27Non ReactiveYesNoNoUsed to SmokeNoYESYesStoredIn Stock
$1,109
Multiple Sclerosis PBMC 72917 121301 Male 46-60 Caucasian Cryopreserved 1 mL 3 10M Ocrevus 600mg - infusion twice a year Aricept 10mg QD Baclofen 30mg BID Trospium chloride 20mg BID Cymbalta 60mg QD Multiple Sclerosis United States 2026 A*03:01:01:01/A*68:01:02:02 — — — — — — — — 184914; 184915; 184918PBMC10M cellsMultiple SclerosisMultiple SclerosisNoMRI contrast48.81ReactiveYesNoNoNoYesNONoARH+StoredIn Stock
$530
Alzheimer's Disease PBMC 78410 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Bisoprolol, Rivastigmine Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211427PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo28.12NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78411 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Bisoprolol, Rivastigmine Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211428PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo28.12NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78413 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Bisoprolol, Rivastigmine Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211430PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo28.12NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78412 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Bisoprolol, Rivastigmine Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211429PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo28.12NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78414 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Bisoprolol, Rivastigmine Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211431PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo28.12NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78535 — Female 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Amiodarone, Donepezil Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211447PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo31.12NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78536 — Female 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Amiodarone, Donepezil Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211448PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo31.12NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78537 — Female 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Amiodarone, Donepezil Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211449PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo31.12NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78538 — Female 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Amiodarone, Donepezil Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211450PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo31.12NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78539 — Female 61+ Caucasian Cryopreserved 1.5 mL 1 10M Acetylsalicylic acid, Amiodarone, Donepezil Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211451PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo31.12NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78445 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Nicotinic acid, Bisoprolol, Rivastigmine Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211464PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo33.73NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78446 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Nicotinic acid, Bisoprolol, Rivastigmine Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211465PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo33.73NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78447 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Nicotinic acid, Bisoprolol, Rivastigmine Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211466PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo33.73NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78448 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Nicotinic acid, Bisoprolol, Rivastigmine Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211467PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo33.73NoNoNoStoredIn Stock
$891
Alzheimer's Disease PBMC 78449 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Nicotinic acid, Bisoprolol, Rivastigmine Alzheimer's Disease Ukraine 2026 — — — — — — — — — 211468PBMC10M cellsAlzheimer's DiseaseAlzheimer's diseaseNo33.73NoNoNoStoredIn Stock
$891
Multiple Sclerosis PBMC 75571 101223 Female 46-60 Caucasian Cryopreserved 1 mL 59 50M Flexeril 10 mg QD Vit D 10, 000 IU's po QD B-12 QM Zofran PRN Bcomplex QD Klonopin .5 PRN Nurtec 75mg PRN Multiple Sclerosis United States 2026 — — — — — — — — — 200790; 200789; 200786; 200785; 200784; 200782; 200783; 200781; 200780; 200777; 200778; 200776; 200779; 200773; 200775; 200774; 200772; 200770; 200766; 200771; 200769; 200768; 200767; 200765; 200763; 200764; 200762; 200761; 200760; 200759; 200758; 200757; 200747; 200754; 200746; 200755; 200756; 200744; 200745; 200743; 200742; 200801; 200799; 200800; 200798; 200797; 200795; 200794; 200793; 200792; 200796; 200791; 200788; 200753; 200752; 200750; 200751; 200748; 200749PBMC50M cellsMultiple SclerosisMultiple SclerosisYesaZithromycin, Ultram, and cephalaxin32.48NoNoNoUsed to Smoke200.5NoNOYesStoredIn Stock
$1,109
Multiple Sclerosis PBMC 75352 136357 Female 46-60 Caucasian Cryopreserved 1 mL 47 50M Trazadone 150 mg PRN Albuterol PRN Magnesium 500mg QN Metoprolol 25mg ER QD Xanax 0.5 mg qd PRN Flexeral 10mg PRN Vumerity Vitamin D3 2, 000 IC Normethadone Black cohosh supplement menopause Multiple Sclerosis United States 2026 — — — — — — — — — 199959; 199958; 199957; 199956; 199955; 199954; 199953; 199952; 199951; 199950; 199949; 199947; 199946; 199945; 199944; 199943; 199942; 199941; 199940; 199939; 199938; 199937; 199936; 199935; 199934; 199933; 199932; 199931; 199930; 199929; 199928; 199927; 199926; 199925; 199924; 199917; 199916; 199915; 199914; 199913; 199912; 199923; 199922; 199921; 199920; 199919; 199918PBMC50M cellsMultiple SclerosisMultiple SclerosisNo21.16NoNoNoUsed to Smoke50.5YesNOYesStoredIn Stock
$1,109
Multiple Sclerosis PBMC 73734 153980 Female 31-45 Caucasian Native American Cryopreserved 1 mL 22 50M Gilenya (fingolimod)- DMT Multiple Sclerosis United States 2026 — — — — — — — — — 189433; 189429; 189432; 189434; 189430; 189427; 189425; 189428; 189426; 189431; 189415; 189412; 189417; 189416; 189413; 189414; 189422; 189424; 189419; 189420; 189418; 189421PBMC50M cellsMultiple SclerosisMultiple SclerosisNo21.92Non ReactiveYesNoNoUsed to SmokeYesYESYesStoredIn Stock
$1,109
Parkinson's Disease PBMC 81351 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Levodopa, Carbidopa, Acetylsalicylic acid, Bisoprolol Parkinson's Disease Ukraine 2026 — — — — — — — — — 270766PBMC10M cellsParkinson's DiseaseParkinson's diseaseNo27.57NoNoNoStoredIn Stock
$765
Parkinson's Disease PBMC 81353 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Levodopa, Carbidopa, Acetylsalicylic acid, Bisoprolol Parkinson's Disease Ukraine 2026 — — — — — — — — — 270768PBMC10M cellsParkinson's DiseaseParkinson's diseaseNo27.57NoNoNoStoredIn Stock
$765
Parkinson's Disease PBMC 81352 — Male 61+ Caucasian Cryopreserved 1.5 mL 1 10M Levodopa, Carbidopa, Acetylsalicylic acid, Bisoprolol Parkinson's Disease Ukraine 2026 — — — — — — — — — 270767PBMC10M cellsParkinson's DiseaseParkinson's diseaseNo27.57NoNoNoStoredIn Stock
$765

Showing 1–25 of 551 lots

Access a comprehensive portfolio of neuroscience-focused biospecimens

Our donor network across the United States supports research into major neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, and a broad range of other neurological conditions. Whether you need cross-sectional or longitudinal collections, matched sample sets, or custom cohorts, we provide the precise specimens and deep annotation required for breakthrough neuroscience research.

Why Choose Sanguine for Neuro Disease Specimen Solutions

Neurodegenerative disease research demands high-quality biospecimens, rigorous donor annotation, and compliance with ethical standards.

Direct-to-donor model & engaged donor network

Our nationwide network allows access to well-characterized donors, streamlining procurement so you can focus on discovery.

Custom collection services

If what you need isn’t available in our inventory, we will recruit and collect from a custom cohort tailored to your specific inclusion/exclusion criteria.

Access to hard-to-find populations

Neurodegenerative disease states, early vs late stage, treatment-naïve vs treated — we work with you to source the right donors.

Matched sample sets

Get multiple sample types from the same donor (e.g., blood, PBMC) for holistic biomarker analysis.

Comprehensive clinical & molecular annotation

Receive samples paired with rich donor data — demographics, disease history, treatment and outcomes, and imaging when available.

Ethical sourcing & regulatory compliance

Our processes meet high ethical and data-security standards (ISO certifications, data privacy) which gives you confidence in your research tools

Neuro Disease Specimen Portfolio

Available specimen types include:

Plasma & serum

Whole blood & PBMCs

Longitudinal (serial) collections to track disease progression and response to intervention

Rich clinical and molecular annotation:

Many of our neuroscience biospecimens come with detailed donor documentation, enabling them to function as true translational research tools.

Demographics & clinical characteristics

Diagnosis and stage, age at onset, gender, race/ethnicity, family history, comorbidities

Treatment history

Medication exposures (e.g., dopamine agonists, cholinesterase inhibitors), surgical interventions (e.g., DBS), other therapie

Molecular profiling

Where available, data may include biomarker levels (e.g., alpha synuclein, tau, neurofilament light chain), genetic or genomic data, copy number variation, gene expression profiles

Outcomes data

Progression rates, cognitive/functional decline metrics, treatment response, longitudinal follow-up

Ethical Sourcing and Regulatory Compliance

Trust and compliance are fundamental to our operations.

Ethical Sourcing

Ethical standards:

  • Institutional Review Board (IRB)-approved donor consent documentation
  • Donors engaged through transparent, compliant recruitment and consent processes Regulatory & data security:
  • De-identified donor data in HIPAA-compliant format
  • Certified quality management systems including ISO 9001, ISO 27001, ISO 27701 for information security and privacy. PR Newswire+1 (opens in new tab)

From Discovery to Therapy — Powering Every Step of Neuro Research

Whether you’re exploring disease pathogenesis, developing diagnostics, or validating therapeutic strategies, our biospecimens supportresearch across the neuroscience continuum:

Basic research

Investigate mechanisms of neurodegeneration, synaptic dysfunction, protein aggregation (e.g., tau, alpha-synuclein)

Biomarker discovery & validation

Use longitudinal sets and matched controls to identify prognostic or predictive markers (e.g., neurofilament light chain, imaging correlates)

Therapeutic development

Support drug discovery and clinical validation with well-characterized donor samples, treatment-naïve and treated cohorts

Precision neuroscience

Leverage genomic profiling in samples linked to phenotypic and outcomes data to enable precision medicine approaches

Diagnostics development

Develop and validate assays for early detection or progression of Alzheimer’s, Parkinson’s or other neurodegenerative diseases

Ready to Advance Your Neurodegenerative Disease Research?

Our donor network across the United States supports research into major neurodegenerative conditions such as Alzheimer’s disease, Parkinson’s disease, and a broad range of other neurological conditions. Whether you need cross-sectional or longitudinal collections, matched sample sets, or custom cohorts, we provide the precise specimens and deep annotation required for breakthrough neuroscience research.